Scholar Rock Holding (SRRK) EBITDA (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly EBITDA came in at -$102.0 million in Q1 2026, down 32.33% year-on-year from -$150.8 million in Q1 2025, and down 11.01% quarter-over-quarter from -$91.9 million in Q4 2025.

Scholar Rock Holding (SRRK) EBITDA (2017 - 2026) Analysis & Trends

Scholar Rock Holding's EBITDA history runs 10 years deep, the most recent figure standing at -$102.0 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 32.33% year-over-year to -$102.0 million in Q1 2026; TTM through Mar 2026 was -$409.6 million, a 51.29% decrease from a year earlier, with the FY2025 full-year figure at -$384.6 million, down 52.6% from the prior year.
  • EBITDA retreated to -$102.0 million in Q1 2026 per SRRK's latest filing, from -$91.9 million in the prior quarter.
  • Across five years, EBITDA topped out at -$6.9 million in Q1 2022 and bottomed at -$112.1 million in Q2 2025.
  • The 5-year median for EBITDA is -$58.4 million (2024), against an average of -$61.4 million.
  • Across the five-year window, EBITDA jumped 74.52% in 2022 and sank 484.29% in 2023, its largest moves.
  • Year by year, EBITDA stood at -$40.4 million in 2022, then fell by 18.81% to -$48.0 million in 2023, then sank by 44.4% to -$69.4 million in 2024, then sank by 32.5% to -$91.9 million in 2025, then slipped by 11.01% to -$102.0 million in 2026.
  • Per Business Quant, the three latest SRRK EBITDA figures stand at -$102.0 million (Q1 2026), -$91.9 million (Q4 2025), and -$103.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -27.75 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 249.90 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 394.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -445.22 Mn
10 Scholar Rock Holding 6.10 Bn 6.10 Bn - -102.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -102.02 Mn
Dec 31, 2025 -91.90 Mn
Sep 30, 2025 -103.55 Mn
Jun 30, 2025 -112.11 Mn
Mar 31, 2025 -77.09 Mn
Dec 31, 2024 -69.36 Mn
Sep 30, 2024 -64.78 Mn
Jun 30, 2024 -59.50 Mn
Mar 31, 2024 -58.42 Mn
Dec 31, 2023 -48.03 Mn
Sep 30, 2023 -43.67 Mn
Jun 30, 2023 -39.08 Mn
Mar 31, 2023 -40.51 Mn
Dec 31, 2022 -40.43 Mn
Sep 30, 2022 -43.86 Mn
Jun 30, 2022 -43.15 Mn
Mar 31, 2022 -6.93 Mn
Dec 31, 2021 -35.36 Mn
Sep 30, 2021 -37.08 Mn
Jun 30, 2021 -30.27 Mn